<p>Summary of characteristics of selected studies for primary and secondary outcomes in patients with relapsed or refractory peripheral T-cell lymphoma treated with various salvage therapies.</p
This analysis explored factors influencing survival of patients with primary refractory and relapsed...
Full list of author information is available at the end of the articleDiffuse large B-cell lymphoma ...
OBJECTIVES : To study the clinical profile, relative proportions and outcome with treatment of pati...
The goal of this study was to perform a systematic review to examine the efficacy and safety of vari...
BACKGROUND:The goal of this study was to perform a systematic review to examine the efficacy and saf...
This analysis explored factors influencing survival of patients with primary refractory and relapsed...
<P>Peripheral T-cell lymphoma (PTL) is a distinctive clinical entity, albeit it comprises se...
Treatment patterns and clinical outcomes among patients with relapsed/refractory classical Hodgkin’s...
Supplemental Table 1. Baseline demographic and clinical characteristics of the overall, untreated an...
1 概述 外周T细胞淋巴瘤(peripheral T-cell lymphoma,PTCL)占非霍奇金淋巴瘤(NHL)的5%~15%,呈现明显的异质性,即临床和病理形态的多样性.PTCL-非特指型淋巴...
Historic outcomes for patients with relapsed or refractory nodal-based T-cell lymphomas are poor, wi...
Peripheral T-cell lymphoma (PTCL) is a rare, heterogeneous malignancy. Of the 619 patients with rela...
Background: Outcomes for patients with peripheral T-cell lymphoma (PTCL) who fail to achieve complet...
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of clinically aggressive diseases asso...
Peripheral T-cell lymphomas (PTCLs) are rare neoplasms that recently have been the subject of much r...
This analysis explored factors influencing survival of patients with primary refractory and relapsed...
Full list of author information is available at the end of the articleDiffuse large B-cell lymphoma ...
OBJECTIVES : To study the clinical profile, relative proportions and outcome with treatment of pati...
The goal of this study was to perform a systematic review to examine the efficacy and safety of vari...
BACKGROUND:The goal of this study was to perform a systematic review to examine the efficacy and saf...
This analysis explored factors influencing survival of patients with primary refractory and relapsed...
<P>Peripheral T-cell lymphoma (PTL) is a distinctive clinical entity, albeit it comprises se...
Treatment patterns and clinical outcomes among patients with relapsed/refractory classical Hodgkin’s...
Supplemental Table 1. Baseline demographic and clinical characteristics of the overall, untreated an...
1 概述 外周T细胞淋巴瘤(peripheral T-cell lymphoma,PTCL)占非霍奇金淋巴瘤(NHL)的5%~15%,呈现明显的异质性,即临床和病理形态的多样性.PTCL-非特指型淋巴...
Historic outcomes for patients with relapsed or refractory nodal-based T-cell lymphomas are poor, wi...
Peripheral T-cell lymphoma (PTCL) is a rare, heterogeneous malignancy. Of the 619 patients with rela...
Background: Outcomes for patients with peripheral T-cell lymphoma (PTCL) who fail to achieve complet...
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of clinically aggressive diseases asso...
Peripheral T-cell lymphomas (PTCLs) are rare neoplasms that recently have been the subject of much r...
This analysis explored factors influencing survival of patients with primary refractory and relapsed...
Full list of author information is available at the end of the articleDiffuse large B-cell lymphoma ...
OBJECTIVES : To study the clinical profile, relative proportions and outcome with treatment of pati...